BMS-986277

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986277, covering 2020-12-19 to 2020-12-19. Get the full timeline:

Most recent: Clinical Trial Update: An Investigational Immuno-Therapy Study of Experimental Medication BMS-986277 Given Alone and in Combination With Nivolumab in Epithelial Cancers [Phase 1, Phase 2]

See pricing